Show Search Form
human indexable | ||||||||
---|---|---|---|---|---|---|---|---|
published | ||||||||
registered interest | ||||||||
answer date | ||||||||
date | ||||||||
date tabled | ||||||||
ddp created | ||||||||
answering body |
|
|||||||
question status | Tabled | |||||||
answering dept id | 17 | |||||||
answering dept short name | Health and Social Care | |||||||
answering dept sort name | Health and Social Care | |||||||
ddp modified |
|
|||||||
hansard heading | Drugs: Prices | |||||||
house id | 1 | |||||||
identifier | 163828 | |||||||
legislature |
|
|||||||
parliament number | 58 | |||||||
question first answered |
|
|||||||
question text | To ask the Secretary of State for Health and Social Care, pursuant to the answer of 30 January 2023 to Question 129959 on Drugs: Prices, how many of the 24 commercial agreements that resulted in non-uniform pricing since 2020 were agreed through (a) The Cancer Drugs Fund, (b) routine commissioning and (c) the Innovative Medicines Fund. | |||||||
session |
|
|||||||
session number | 3 | |||||||
tabling member constituency | Bolton West | |||||||
tabling member printed |
|
|||||||
title | House of Commons Tabled Parliamentary Question 2022/23 163828 | |||||||
type |
|
|||||||
uin | 163828 | |||||||
version | 1 | |||||||
written parliamentary question type | Ordinary | |||||||
answer | answer | |||||||
creator |
|
|||||||
publisher | 25259 | |||||||
tabling member |
|